By making DNA accessible to a new world of applications, enzymatic DNA synthesis promises to send the bioeconomy into overdrive. Molecular Assemblies CEO Michael Kamdar talks with SynBioBeta editor Kevin Costa about the DNA synthesis market, the latest advances in enzymatic synthesis, and when Molecular Assemblies will bring this game-changing technology to market.
